Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Personalized treatment plans are important for people with alopecia areata.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

New acne treatments show promise as alternatives to traditional therapies.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

Secukinumab can cause hair loss, which may improve after stopping the medication.